Back to Type 2 Diabetes
NCT01154881
NCT01154881
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with type 2 diabetes for at least 12 months
- Your body mass index (BMI) is 35.0 or below (BMI is a measure based on your height and weight)
Who may not be able to join:
- You have donated blood or plasma in the past month, or donated more than 500 mL (about a pint) of blood in the past 3 months
- You smoke more than 5 cigarettes a day, or the equivalent amount using other tobacco products
- You are not able or willing to stop smoking and avoid nicotine products (such as nicotine gum or nicotine patches) during the time you would need to stay at the trial site
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 1
Sponsor
Novo Nordisk A/S
Registry
clinicaltrials_gov
Start date
1 June 2010
Est. completion
1 November 2010
Where this trial is recruiting
🇩🇪 Germany
Primary endpoints
Area under the glucose infusion rate curve from 0-24 hours at steady state
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.